Inflammatory Bowel Disease News

• Anaemia in Children With IBD: A Persistent Challenge A significant proportion of children newly diagnosed with IBD present with anaemia, and many of them remain anaemic even after a year, warranting adequate attention to the issue.
  Medscape News UK, April 11, 2025
• Is Combo DMARD Therapy Safe for Inflammatory Diseases? In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo therapy than with monotherapy, though some combinations may pose increased risk.
  Medscape Medical News, March 27, 2025
• AI Predicts Premature Death in Patients With IBD Machine learning models can accurately predict premature death in patients with IBD and multiple comorbidities, according to a new study.
  Medscape Medical News, March 27, 2025
• Not All Plant-Based Diets Protect Against IBD Consumption of healthy plant-based diets is associated with a lower incidence of inflammatory bowel disease and related surgeries, according to a large retrospective analysis.
  Medscape Medical News, March 25, 2025
• Alert FDA OKs Guselkumab for Crohn’s Disease Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for moderately to severely active Crohn’s disease.
  Medscape Medical News, March 25, 2025
• Can Ileocaecal Resection Cut Corticosteroid Use in Crohn's? In patients with Crohn's disease and intermediate to high preoperative corticosteroid use, primary ileocaecal resection leads to reduced corticosteroid use after surgery, a study shows.
  Medscape News UK, March 19, 2025
• Axial Involvement in PsA: What Are the Risk Factors? Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and HLA-B27 positivity associated with an increased risk for axial PsA.
  Medscape News UK, March 17, 2025
• Stool Test Detects Sensitivity to Food Additives A simple stool test may reveal why some people are sensitive to food emulsifiers such as CMC, offering insights into IBD risk and potential dietary solutions.
  Medscape Medical News, March 17, 2025
• Psychological Disorders May Adversely Impact IBD Prognosis Patients with active inflammatory bowel disease and coexisting psychological disorders have an increased risk for flares, glucocorticosterioid use, hospitalisations, and death.
  Medscape News UK, March 14, 2025
• Difficult-to-Treat IBD Patients Prefer Dual Biologic Therapy Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.
  Medscape Medical News, March 12, 2025
• Autoimmune Thyroid Diseases May Up Microscopic Colitis Risk A Swedish study reveals a significant association between autoimmune thyroid diseases and an increased risk for microscopic colitis.
  Medscape News UK, March 11, 2025
• ECCO 2025 Vedolizumab Beats Infliximab as Second-Line UC Therapy In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of anti-TNF therapy.
  Medscape Medical News, March 06, 2025
• ECCO 2025 Metabolomic Profiles Predict IBD up to 10 Years Before Onset Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining the systemic nature of the disease.
  Medscape Medical News, March 04, 2025
• Fecal Calprotectin Predicts Disease Extent, Healing in UC Fecal calprotectin levels correlate with disease activity and extent in ulcerative colitis and accurately diagnose mucosal healing.
  Medscape Medical News, March 04, 2025
• ECC0 2025 Subcutaneous Guselkumab Proves Efficacious for IBD For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ulcerative colitis as well as in those with Crohn’s disease.
  Medscape Medical News, February 28, 2025
• ECC0 2025 Anxiety, Depression Linked to IBD Flare The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, emphasizing the need for holistic patient care.
  Medscape Medical News, February 28, 2025
• ECC0 2025 Machine Learning Identifies Gut Biomarkers for IBD A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory bowel disease from healthy control individuals.
  Medscape Medical News, February 27, 2025
• ECC0 2025 New IL-7 Antagonist Lusvertikimab Shows UC Efficacy In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ulcerative colitis.
  Medscape Medical News, February 26, 2025
• ECC0 2025 Virtual Chromoendoscopy Better at Neoplasia Detection in IBD A British study found that virtual chromoendoscopy has a higher neoplasia detection rate than other endoscopic modalities during routine IBD surveillance.
  Medscape Medical News, February 25, 2025
• ECC0 2025 AI Improves Lesion Detection in IBD Over Standard Methods An AI-assisted model detects ulcers and erosions with higher sensitivity and speed than standard-of-care readings in a landmark multicenter, capsule endoscopy study.
  Medscape Medical News, February 24, 2025